Media News

Stavian Chemical Ranks 17th in ICIS Top 100, Signaling Strong Growth Amid Global Market Challenges

HANOI, Vietnam, May 28, 2024 /PRNewswire/ -- Stavian Chemical, a leading global chemical distributor headquartered in Vietnam, proudly announces its exceptional performance in the prestigious ICIS Top 100 Chemical Distributors for 2024. Demonstrating the company's robust growth and resilience in the face of global market challenges, Stavian Chemical has risen to the 17th position as recognized by the Independent...

EVERISE CERTIFIED AS A MOST LOVED WORKPLACE® BY NEWSWEEK FOR FOUR CONSECUTIVE YEARS

Everise ranks among the top 100 global companies recognized for employee sentiment and satisfaction. PLANTATION, Fla., May 28, 2024 /PRNewswire/ -- Everise, a leader in customer experience for global healthcare companies, today announced being ranked on the Top 100 Global Most Loved Workplaces® list, as published by Newsweek. The list, created in collaboration with...

Innovent Announces Picankibart (IBI112) Achieved Primary Endpoints in a Phase 3 Clinical Trial in Treating Moderate to Severe Plaque Psoriasis, and Plans to Submit NDA to the NMPA

SAN FRANCISCO and SUZHOU, China, May 28, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today announced that picankibart (R & D code: IBI112), a recombinant anti-interleukin 23p19 subunit (IL-23p19) antibody injection, has met all the...

Neuren Phase 2 trial shows significant improvements in Pitt Hopkins syndrome

Highlights: Statistically significant improvement from baseline assessed by both clinicians and caregivers in all four efficacy measures specifically designed for Pitt Hopkins syndrome (Wilcoxon signed rank test p<0.05) Clinician and caregiver global efficacy measures showed a level of improvement considered clinically meaningful: - Clinical Global Impression of Improvement (CGI-I) - mean score of 2.6, with 9 out...

Driving a consensus approach to improve the lives and fertility health of women stricken with endometriosis

MANILA, Philippines , May 27, 2024 /PRNewswire/ -- Specialists in reproductive health in the Asia Pacific region are advancing a pathfinding initiative to improve the lives of millions of women around the world who suffer from endometriosis. The debilitating condition affects up to 10 per cent of females with effects including chronic pain...

Chula Medicine Joins Forces with the Department of Thai Traditional and Alternative Medicine to Determine “Curcumin” as Effective Treatment for Dyspepsia as Modern Antacids

Chula Medicine in collaboration with the Department of Thai Traditional and Alternative Medicine and Gastroenterologists from local medical schools proves that Thai curcumin can help treat dyspepsia as effectively as antacids, and is poised to push Thai curcumin to the global marketplace. BANGKOK, May 27, 2024 /PRNewswire/ -- Many people may have experienced bloating, pain, tightness, nausea, and heartburn from dyspepsia,...

Tertiary education and workplace reforms vital to address an Asian Pacific crisis in fertility rates

MANILA, Philippines, May 27, 2024 /PRNewswire/ -- Asian Pacific leaders in reproductive health are calling on tertiary education sectors and employers to introduce family friendly study programs and workplace flexibility measures to help arrest an alarming decline in birth rates. In many countries in the Asia Pacific, total fertility rates have plummeted...

Telix Submits NDA for New Prostate Cancer Imaging Agent

MELBOURNE, Australia, May 27, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has submitted a New Drug Application (NDA) to the United States (U.S.) Food and Drug Administration (FDA) for TLX007-CDx, a new and proprietary cold kit ("Kit") for the preparation of PSMA-PET imaging for prostate...

Critical need for doctors to counsel couples on potential genetic burden in offspring of older dads

MANILA, Philippines, May 26, 2024 /PRNewswire/ -- An increasing trend of older fatherhood is potentially creating a global genetic disaster with devastating health consequences for offspring. A major conference of human reproductive health in the Philippines will hear of mounting evidence that paternal ageing is associated with a profound increase in sperm...

Lunit to Showcase 7 Studies at ASCO 2024, including AI Innovations in HER2 Quantification, and Multimodal Predictive Models for Immunotherapy Response

- Lunit's ASCO 2024 presentations to highlight advances including HER2 ultra-low detection and AI-powered ICI response prediction models for NSCLC, demonstrating the impact of Lunit SCOPE suite on precision oncology SEOUL, South Korea, May 24, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today...